(Total Views: 512)
Posted On: 07/30/2019 2:50:23 PM
Post# of 72446
Great article:
Summary/Conclusion:
Our results show kevetrin alters several key genes and cellular metabolism. Along with cellular data, this study could provide a rationale for an experimental trial in AML patients, especially those carrying TP53 mutation who actually have very few therapeutic options.
Summary/Conclusion:
Our results show kevetrin alters several key genes and cellular metabolism. Along with cellular data, this study could provide a rationale for an experimental trial in AML patients, especially those carrying TP53 mutation who actually have very few therapeutic options.
(4)
(0)
